Eyewire News: The Podcast
01.07.26
Shareholders vote on Alcon’s blockbuster acquisition proposal for Staar Surgical; the FDA responds to Outlook’s latest BLA submission for wet AMD drug Lytenava; and the FDA approves an interchangeable biosimilar to Lucentis. Learn more about your ad choices. Visit megaphone.fm/adchoices
View full description +
Subscribe
01.07.26
Staar Terminates Merger with Alcon12.31.25
2025 Year in Review - Part 212.24.25
2025 Year in Review - Part 112.17.25
Update on Reproxalap PDUFA Timing11.18.25
Live Coverage of B+L Investor DayShow More